Denis Maxime, Haidar Bassam, Marcil Michel, Bouvier Michel, Krimbou Larbi, Genest Jacques
Cardiovascular Genetics Laboratory, Cardiology Division, McGill University Health Centre/Royal Victoria Hospital, Montréal, Québec H3A 1A1, Canada.
J Biol Chem. 2004 Oct 1;279(40):41529-36. doi: 10.1074/jbc.M406881200. Epub 2004 Jul 26.
The oligomeric structure of ABCA1 transporter and its function related to the biogenesis of nascent apoA-I-containing particles (LpA-I) were investigated. Using n-dodecylmaltoside and perfluoro-octanoic acid combined with non-denaturing gel, the majority of ABCA1 was found as a tetramer in ABCA1-induced human fibroblasts. Furthermore, using chemical cross-linking and SDS-PAGE, ABCA1 dimers but not the tetramers were found covalently linked. Oligomeric ABCA1 was present in isolated plasma membranes as well as in intracellular compartments. Interestingly, apoA-I was found to be associated with both dimeric and tetrameric, but not monomeric, forms of ABCA1. Neither apoA-I nor lipid molecules did affect ABCA1 oligomerization. Immunoprecipitation analysis showed that oligomeric ABCA1 did not contain other associated proteins. We next investigated the relationship between the oligomeric ABCA1 complex and the structure of LpA-I. Lipid-free apoA-I incubated with normal cells generated LpA-I with diameters between 9.5 and 20 nm. Subsequent isolation of LpA-I followed by cross-linking revealed the presence of four and eight apoA-I molecules per particle, whereas apoA-I incubated with ABCA1 mutant (Q597R) cells was unable to form such particles and remained in the monomeric form. These results demonstrate that: 1) ABCA1 exists as an oligomeric complex; and 2) ABCA1 oligomerization was independent of apoA-I binding and lipid molecules. The findings that the majority of ABCA1 exists as a tetramer that binds apoA-I, together with the observation that LpA-I contains at least four molecules of apoA-I per particle, support the concept that the homotetrameric ABCA1 complex constitutes the minimum functional unit required for the biogenesis of high density lipoprotein particles.
研究了ABCA1转运蛋白的寡聚结构及其与含新生载脂蛋白A-I颗粒(LpA-I)生物合成相关的功能。使用正十二烷基麦芽糖苷和全氟辛酸结合非变性凝胶,在ABCA1诱导的人成纤维细胞中发现大多数ABCA1为四聚体。此外,通过化学交联和SDS-PAGE发现ABCA1二聚体而非四聚体以共价键相连。寡聚ABCA1存在于分离的质膜以及细胞内区室中。有趣的是,发现载脂蛋白A-I与ABCA1的二聚体和四聚体形式相关,但不与单体形式相关。载脂蛋白A-I和脂质分子均不影响ABCA1的寡聚化。免疫沉淀分析表明寡聚ABCA1不包含其他相关蛋白。接下来,我们研究了寡聚ABCA1复合物与LpA-I结构之间的关系。与正常细胞孵育的无脂质载脂蛋白A-I产生直径在9.5至20nm之间的LpA-I。随后分离LpA-I并进行交联,结果显示每个颗粒存在四个和八个载脂蛋白A-I分子,而与ABCA1突变体(Q597R)细胞孵育的载脂蛋白A-I无法形成此类颗粒,而是保持单体形式。这些结果表明:1)ABCA1以寡聚复合物形式存在;2)ABCA1的寡聚化独立于载脂蛋白A-I结合和脂质分子。大多数ABCA1以结合载脂蛋白A-I的四聚体形式存在,以及LpA-I每个颗粒至少包含四个载脂蛋白A-I分子的观察结果,支持了同型四聚体ABCA1复合物构成高密度脂蛋白颗粒生物合成所需的最小功能单元这一概念。